Sonidegib Shortage Update: What Patients Need to Know in 2026

If you've been prescribed Sonidegib (Odomzo) and are struggling to get it filled, you may be wondering: Is there a shortage? Here's what you need to know about Sonidegib availability in 2026, why access remains challenging, and what it means for your treatment.

Is Sonidegib Currently in a Shortage?

As of 2026, Sonidegib (Odomzo) is not on the FDA's official drug shortage list. The manufacturer, Sun Pharmaceutical Industries, continues to produce and distribute Odomzo. However, this does not mean the drug is easy to access. Sonidegib has a structural access challenge that makes it feel like a shortage for many patients.

Why Does It Feel Like a Shortage If There Isn't One?

The confusion is understandable. Here's why patients experience difficulty getting Sonidegib even when the drug is technically available:

Specialty-only distribution: Sonidegib is only dispensed through Sun Pharma's OdomzoCARE specialty pharmacy network. Retail pharmacies do not carry it and cannot order it. Walking into any standard pharmacy will result in a dead end.

Prior authorization delays: Most insurance plans require prior authorization before covering Sonidegib, a process that can take days or weeks.

High cost as a barrier: The cash price of approximately $14,800 for a 30-day supply makes it inaccessible without insurance or patient assistance programs.

No generic available: Unlike many medications, Sonidegib has no generic equivalent, meaning there is no alternative supply chain patients can tap into.

A Brief History of Sonidegib Access Issues

Sonidegib was originally developed and marketed by Novartis under the Odomzo brand when it received FDA approval in July 2015. Sun Pharmaceutical Industries later acquired the U.S. commercialization rights. Throughout its history, Odomzo has remained a niche specialty drug for a relatively small patient population—adults with locally advanced BCC who have exhausted other treatment options.

Unlike drugs such as Adderall or semaglutide that have experienced broad demand-driven shortages, Sonidegib's access challenges are primarily driven by its specialty pharmacy distribution model and the insurance prior authorization process—not by manufacturing supply issues.

What Patients Should Do Right Now

If you're having trouble accessing Sonidegib, here are the most important steps to take in 2026:

Verify the prescription went to the right place. Confirm your doctor sent the prescription to an OdomzoCARE specialty pharmacy, not a retail location.

Contact Sun Pharma's support line. Call 1-877-636-6961 to get connected with OdomzoCARE patient support services, which can help navigate insurance and specialty pharmacy access.

Push for faster prior authorization. Ask your oncologist to prioritize getting the PA submitted with full documentation.

Explore financial assistance programs. The Sun Pharma co-pay card can reduce costs to as little as $10/month for commercially insured patients. The Patient Assistance Program may provide it at no cost for uninsured patients.

Ask about alternatives. If access delays are serious, speak with your oncologist about Vismodegib (Erivedge), which is in the same drug class and may be available through a different specialty pharmacy network.

38,004+ patients found their medications in stock

38K+

Find Sonidegib In Stock Today →

How to Stay Updated on Sonidegib Availability

The FDA maintains an official drug shortage database at accessdata.fda.gov/scripts/drugshortages. You can search for "sonidegib" or "Odomzo" to see if any shortage is ever officially declared. As of 2026, no shortage is listed.

How medfinder Helps Patients Navigate Access Issues

Whether or not there is an official shortage, medfinder helps patients find which pharmacies can fill their specific prescription. You provide your medication, dosage, and ZIP code—medfinder calls pharmacies and texts you the results. Read more about how to find Sonidegib in stock near you for a detailed guide.

Skip the calls, skip the stress.

Find Sonidegib In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Bottom Line

Sonidegib is not officially in shortage as of 2026, but structural access barriers—specialty pharmacy restrictions, prior authorization, and high cost—create real challenges for patients. Being proactive, working closely with your oncology team and OdomzoCARE support services, and exploring financial assistance programs are your best paths to getting this medication.